Bedside Snapshot

Indications
  • Stable, regular, narrow-complex tachycardia (AVNRT, AVRT)
  • Adults first; the trial excluded AF and flutter
  • Before adenosine, when the patient is stable
Contraindications / Abort
  • Unstable: hypotension, altered mental status, chest pain, heart failure. Cardiovert.
  • Irregular or wide-complex rhythm
  • Patient deteriorates during the maneuver: stop
Critical Steps
  • Strain 15 s at 40 mm Hg
  • Lie supine, legs raised, immediately after the strain
  • Read the strip at 1 min
Confirm & Monitor
  • Sinus rhythm on the strip at 1 min
  • BP and SpO₂ before, during and after
  • Adenosine 6 mg, then 12 mg if still SVT

Key Numbers

Vagal maneuvers slow AV-node conduction and can end AVNRT or AVRT. In the REVERT trial, the modified maneuver returned sinus rhythm in 43% of adults vs 17% with the standard maneuver at 1 minute.

ParameterValue
Strain
15 s at 40 mm Hg, as tested in REVERT. Use the pressure device or method your protocol specifies.
Position change
Immediately after the strain: lie supine and raise the legs (passive leg raise)
Success check
Sinus rhythm on a rhythm strip at 1 min after the maneuver (the REVERT primary outcome)
Conversion (REVERT)
Modified 43% (93 of 214) vs standard 17% (37 of 214); adjusted OR 3.7
Eligible rhythm
Stable, regular narrow-complex tachycardia. Not AF or flutter (excluded from REVERT)
Adult adenosine if no conversion
6 mg rapid IV/IO push, then 12 mg in 1–2 min (max 12 mg per dose; label allows one more 12 mg)
Unstable tachycardia
Synchronized cardioversion, not vagal maneuvers: initial energy per protocol (commonly 100 J for narrow-complex tachycardia)
Infants and children
PALS SVT technique and pathway per protocol; see Pediatric Tachycardia and SVT
Most lethal error: Spending time on a vagal maneuver while an unstable patient waits for synchronized cardioversion.

Overview & Principles

A vagal maneuver pushes up parasympathetic (vagal) tone at the AV node, and the node slows down. In AVNRT or AVRT, that can break the re-entry circuit (AVRT here includes orthodromic AVRT in WPW). Use it as a first step in a stable patient. It is not a treatment for AF or flutter.

How It Works

  • Strain: the patient breathes out hard against a closed airway. Intrathoracic pressure climbs, and that reflex slows AV conduction.
  • Release: pressure drops and the vagal brake comes off. The modified version raises the legs at that same moment to boost venous return.
  • Result: if it works, the re-entry rhythm stops. You see an abrupt return to sinus rhythm on the strip.

Where It Fits

Stable and regular, narrow complex: vagal maneuver first, then adenosine. Still in SVT? Move to the AV-nodal blockers on their own pages. Unstable? Cardiovert.

ManeuverStrainAfter the strainSinus rhythm at 1 min
Standard Valsalva
15 s at 40 mm Hg, semi-recumbent
Remain semi-recumbent
17% (37 of 214)
Modified Valsalva
15 s at 40 mm Hg, semi-recumbent
Lie supine, passive leg raise immediately
43% (93 of 214)
Why it matters: The REVERT authors recommend the modified maneuver as routine first treatment for SVT. If a patient can learn it, teach it.

Indications & Contraindications

Indications

  • Stable regular narrow-complex tachycardia: AVNRT or orthodromic AVRT on a regular rhythm with a narrow QRS.
  • Adults first: REVERT enrolled adults with SVT. AF and flutter were left out.

Absolute Contraindications

  • Unstable patient: hypotension, altered mental status, ischemic chest pain or acute heart failure with the tachycardia. Cardiovert instead.
  • Irregular or wide-complex tachycardia: don't use the maneuver on it. Wide and regular is VT until proven otherwise.

Relative Contraindications & Cautions

  • Cannot follow the strain instruction: use the protocol's alternative for that patient.
  • Pre-excited rhythm (WPW) with AF: no AV-nodal blockers. A vagal maneuver doesn't treat pre-excited AF.
Life over the maneuver: The patient gets worse during or after the maneuver? Stop. Reassess. Move to synchronized cardioversion per protocol. Don't finish the sequence.

Scope & Team Roles

Provider LevelTypical RoleNotes
EMT
Performs (protocol/credentialing required)
Often taught as a stable-patient maneuver; some systems keep it with ALS. Confirm local scope.
AEMT
Performs (protocol/credentialing required)
Pairs with adenosine decisions under the local protocol.
Paramedic
Performs
Owns the 12-lead, the drug decision and the cardioversion decision.
RN (ED/ICU)
Assists
Monitor, time, and prepare the drug under order.
Critical Care Transport
Performs (protocol/credentialing required)
Same drug and cardioversion decisions in transport; watch for hypotension.
Physician / APP
Performs
Sets the order set and handles refractory or unusual rhythms.

Team Roles During the Procedure

  • Operator: explains the maneuver, coaches the strain and leads the leg raise.
  • Monitor reader: watches the rhythm strip and calls the time of the release.
  • Medication clinician: prepares adenosine with a flush and a second check of the dose.
  • Recorder: documents the time, pressure and response.
Note: Scope varies by state, agency and facility. Follow your local protocols and medical direction.

Pre-Procedure Assessment

Rhythm Check

  • Regular and narrow: the usual target. Confirm with a 12-lead where the protocol allows it.
  • Irregular: not a vagal maneuver candidate. Treat per the atrial fibrillation pathway.
  • Wide: treat it as VT unless proven otherwise. Adenosine only for a regular monomorphic rhythm, under expert guidance or protocol. No other AV-nodal blocker (verapamil, diltiazem, beta-blocker).

Physiologic Risk

  • Hypotension: SBP <90 mmHg with the tachycardia is an unstable pattern. Cardiovert.
  • Mental status and chest pain: either one pushes you toward cardioversion.
  • Baseline: record SpO₂ and blood pressure before the maneuver. Without them, a later change is hard to see.
Record the baseline: Rate and blood pressure before the strain. That is your reference for the one-minute check.

Equipment & Preparation

Equipment

  • Cardiac monitor: continuous ECG with a rhythm strip you can save or print.
  • 12-lead ECG: when the protocol allows, before the maneuver.
  • Pulse oximeter and blood pressure cuff: baseline and during the maneuver.
  • Defibrillator with pads: set for synchronized cardioversion and ready for the unstable path.
  • Adenosine: 6 mg and 12 mg rapid-bolus vials with a saline flush, per your stock.
  • Pressure device: the manometer or other method your protocol uses to hold the strain near 40 mm Hg.

Patient Positioning & Preparation

  • Start semi-recumbent: sitting up, upper body reclined, so the leg raise can be done immediately.
  • Explain the sequence: blow out against the closed mouth and nose for 15 seconds, then lie back as directed.

Pre-Procedure Checklist

  • Monitor on and rhythm strip running
  • Stable: confirm no hypotension, altered mental status, chest pain or heart failure
  • Regular narrow-complex rhythm confirmed on the strip or 12-lead
  • Baseline heart rate, BP and SpO₂ recorded with the time
  • Patient instructed; cannot-strain alternative known
  • Defibrillator and pads in reach
  • Adenosine drawn up or in reach with a flush
  • Time of maneuver start written down

Medications & Settings

Typical adult and pediatric references only. Verify them against local protocol and current drug labeling. Doses vary by protocol; follow local protocols and medical direction.

DrugAdult DosePediatric DoseOnset / DurationNotes
Adenosine
6 mg rapid IV/IO push over 1–2 s, then a rapid NS flush; if no conversion in 1–2 min, 12 mg; may repeat 12 mg once max 12 mg per dose
0.1 mg/kg rapid IV/IO push, then 0.2 mg/kg max 6 mg, then max 12 mg
Seconds / under 1 min
Rapid push: use a flush and run a rhythm strip during every push. Transient asystole and flushing are expected.
Synchronized cardioversion (unstable only)
Narrow-complex tachycardia: initial energy per protocol (commonly 100 J synchronized)
0.5–1 J/kg, then 2 J/kg
Immediate
See Synchronized Cardioversion. Re-engage SYNC before each shock.
Second-line AV-nodal blockers
Diltiazem, verapamil or metoprolol per their pages if adenosine fails
Not established or specialist use in infants: see the medication pages
See each page
Only for a regular narrow tachycardia without pre-excitation. Avoid in hypotension, decompensated heart failure or reduced EF (diltiazem and verapamil; metoprolol is contraindicated in decompensated HF). Do not give a beta-blocker and a calcium channel blocker together or within a few hours. Check BP after the dose.

Adenosine Cautions

  • Contraindicated: second- or third-degree AV block, or sick sinus syndrome, without a pacemaker (FDA label).
  • Avoid: asthma or bronchospasm (FDA label).
  • Central line or heart transplant: the label dosing is for peripheral IV. Central venous use has not been systematically studied. Some protocols start lower, at 3 mg here. Follow your protocol.
  • Interactions: caffeine and theophylline blunt the effect. Dipyridamole boosts it, so a smaller dose may be enough. Carbamazepine can deepen heart block (FDA label).

Full list: Adenosine.

Adenosine is not a substitute for the maneuver: Stable patient? Run the modified maneuver first, then adenosine in the order your protocol sets.

Step-by-Step Procedure

Phase 1: Prepare

  1. Confirm the rhythm and stability: regular, narrow, and no hypotension, altered mental status, chest pain or heart failure.
  2. Record the baseline: rate, BP, SpO₂ and the time on the strip.
  3. Position the patient: sitting semi-recumbent, with the legs ready to lift.
  4. Explain the maneuver: one long, forced breath out for 15 seconds, then lie back as you direct.

Phase 2: Perform

  1. Start the strain: the patient exhales against a closed airway, holding about 40 mm Hg for 15 seconds.
  2. Lie back and raise the legs immediately: do not wait after the strain ends.
  3. Watch the strip: keep the rhythm running through the minute.
Stop if unstable: Hypotensive or confused during the maneuver? Stop, and move to the unstable pathway.
Three steps of the modified Valsalva: strain 15 s at 40 mm Hg, lie back with legs raised, check rhythm at 1 minute
Figure 1: The modified Valsalva sequence as tested in the REVERT trial. Source: E3 Learning

Phase 3: Confirm & Secure

  1. Read the rhythm at 1 minute: sinus rhythm is success. Record the time.
  2. If still tachycardic: go to adenosine per protocol (6 mg, then 12 mg in adults).
  3. Reassess after each step: rate, BP and rhythm, and stop for any new hypotension.

Alternative Technique: Infants and Children

Many children and infants can't perform the strain. This page doesn't give a pediatric vagal technique. Use the protocol-approved maneuver in your PALS SVT algorithm (see Pediatric Tachycardia and SVT). REVERT tested the maneuver in adults only.

Confirmation & Monitoring

Primary Confirmation

Sinus rhythm on the strip at 1 minute is success. It is the outcome REVERT used. Confirm with a 12-lead when the protocol allows.

Secondary Confirmation

  • Heart rate drops and stays steady after the return to sinus rhythm.
  • Blood pressure recovers once the leg raise is released.
  • No new ectopy or pauses on the strip.
FindingSuccessFailure / Next Step
Rhythm at 1 min
Sinus rhythm
Still SVT: adenosine per protocol
Blood pressure
Stable
Hypotension: lie flat, reassess, go to the unstable pathway
Rate
Slows and stays slow
Rate falls then the tachycardia returns: recurrence, not success
Rhythm type
Regular sinus
Irregular: AF or flutter; do not repeat the maneuver as treatment

Ongoing Monitoring

  • Continuous ECG: until the rhythm has held and the patient is handed off.
  • BP and SpO₂: at baseline, after the maneuver and after each drug push.
False reassurance: A brief slowdown on the monitor, or a pause, is not conversion. Keep the strip running for the full minute. Recheck after any drug.

Troubleshooting

ProblemLikely CauseFix
No conversion
Strain too short or no leg raise
Repeat if the protocol allows, then adenosine
Rate slows, then returns
Transient AV-nodal effect
Watch the strip; adenosine per protocol
Patient cannot strain
Illness, age or instruction
Use the protocol alternative; go to adenosine
Irregular rhythm appears
AF or flutter with the SVT
Not a success; follow the AF pathway
Lightheadedness or hypotension
Vagal response or leg raise on a fragile patient
Lie flat, monitor, reassess; cardiovert if unstable
Pauses on the strip
Vagal effect or adenosine
Expected briefly; confirm return of rhythm

If It Still Fails

  1. Adenosine: per protocol, 6 mg then 12 mg in adults.
  2. Second-line: diltiazem, verapamil or metoprolol per their pages, for a stable regular narrow tachycardia.
  3. Unstable at any point: synchronized cardioversion now.

Complications

ComplicationRecognitionPreventionManagement
Immediate: hypotension
BP falls during or after the strain or leg raise
Check baseline BP; stable patients only
Lie flat, monitor, cardiovert if the patient is unstable
Immediate: brief pause
Pause on the strip, usually after adenosine
Run the strip during every push
Expect return of rhythm; treat per protocol if it persists
Delayed: recurrence
SVT returns after a conversion
Reassess at intervals; document
Re-treat per protocol; arrange ongoing care
Rare: injury from strain
Chest or head discomfort after the strain
Stop when the patient reports discomfort
Assess; treat per protocol. Not reported in REVERT.
Trial safety: Not one serious adverse event was logged by REVERT, across 433 adults enrolled (428 analysed). That was a controlled setting, not a field one.

Special Populations

Pediatrics

  • Scope: This page covers adults. The REVERT trial enrolled adults only. For infants and children, use the protocol-approved vagal technique in your PALS SVT algorithm and the Pediatric Tachycardia and SVT page.
  • Adenosine by weight: 0.1 mg/kg (max 6 mg), then 0.2 mg/kg (max 12 mg), per the PALS dosing on the adenosine page. Use the weight-based dosing and pediatric vital signs references.
  • Unstable child: synchronized cardioversion at 0.5–1 J/kg, then 2 J/kg. See the pediatric shock page.

Older Adults

  • Baseline BP matters: A lower baseline makes hypotension from the strain or leg raise more likely. Monitor closely.

Pregnancy

  • Protocol and obstetric input: The trial did not study pregnancy. Follow the local protocol. Bring in obstetric and cardiology care as the situation requires.
  • Adenosine: the FDA label says no pregnancy studies were done. Use it in pregnancy only if clearly needed.

Post-Procedure Care & Transport

Immediate Aftercare

  • Keep monitoring: the rhythm can recur after the maneuver.
  • Document the response: time, pressure, rhythm and any drug given.

Ongoing Maintenance

  • Rhythm strip: keep it through transfer of care.
  • Recurrence plan: a repeat maneuver or drug per protocol; ongoing care for recurrent SVT.

Transport Considerations

  • Reassess after each move: the leg raise and position change can drop BP.
  • Movement and noise: rely on the monitor, not on feel, for rhythm.

Document & Hand Off

  • Rhythm and the 12-lead if taken: before and after
  • Stability at baseline and during the maneuver
  • Time of strain, pressure and leg raise
  • Rhythm at 1 minute and the response
  • Adenosine doses, times and flush
  • Complications and the recurrence plan

Clinical Pearls & Pitfalls

Pearls

  • Modified beats standard: the leg raise after the strain converted 43% vs 17% in REVERT.
  • Regular and narrow only: aim it at the rhythm it can break. Not AF, not wide complexes.
  • Time the release: write the clock time on the strip. Then the one-minute check is a fact, not a guess.
  • Stable first, shock if not: a maneuver never delays cardioversion for an unstable patient.

Common Pitfalls

  • Standard strain only, no leg raise: use the modified sequence when the patient is stable.
  • Pausing the strip for the drug: keep the rhythm running through the push.
  • Calling a brief slowing a success: confirm sinus rhythm at 1 minute.
  • Repeating the maneuver on an unstable patient: cardiovert.
Teach the patient: The REVERT authors say patients can learn the modified maneuver. That means it can be done at home, under instruction.

Education & Skill Maintenance

Skill Maintenance

  • Practice the 15-second strain and the leg raise on a simulator or a partner.
  • Rehearse the one-minute strip check and the time documentation.
  • Review the adenosine dosing and the rapid-push technique once a year.

References

  1. Appelboam A, Reuben A, Mann C, Gagg J, Ewings P, Barton M, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet. 2015;386(10005):1747–1753. https://doi.org/10.1016/S0140-6736(15)61485-4
  2. Wigginton JG, Agarwal S, Bartos JA, Coute RA, Drennan IR, Haamid A, et al. Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2):S538–S577. https://doi.org/10.1161/cir.0000000000001376
  3. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2020;41(5):655–720. https://doi.org/10.1093/eurheartj/ehz467
  4. Michaud A, Lang E. Leg lift Valsalva maneuver for treatment of supraventricular tachycardias. CJEM. 2017;19(3):235–237. https://doi.org/10.1017/cem.2016.341
  5. Chen C, Tam TK, Sun S, Guo Y, Teng P, Jin D, Xu L, Liu X. A multicenter randomized controlled trial of a modified Valsalva maneuver for cardioversion of supraventricular tachycardias. Am J Emerg Med. 2020;38(6):1077–1081. https://doi.org/10.1016/j.ajem.2019.158371
  6. Lasa JJ, Dhillon GS, Duff JP, Hayes J, Kamath-Rayne BD, Levy A, Mahgoub M, Morgan RW, McCormick T, Roberts JS, Ross CE, Schexnayder SM, Sweberg T, Valdés SO, Topjian AA. Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2):S479–S537. https://doi.org/10.1161/cir.0000000000001368
  7. U.S. Food and Drug Administration. Adenosine injection, USP [prescribing information]. DailyMed; set ID 1809fc7e-f5d8-18d8-e063-6394a90a7713; label effective 2024-05-09. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1809fc7e-f5d8-18d8-e063-6394a90a7713

Last updated Spotted something wrong? Report an error and include the page URL.

Medical Disclaimer
  • For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
  • Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
  • Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
AI was used to assist in organizing, paraphrasing, and formatting this information.